dr. reckamp on met-targeting strategies in nsclc
Published 6 years ago • 192 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
1:11
dr. reckamp on targeted therapy options for rare mutations in nsclc
-
0:49
dr. reckamp on molecular testing in lung cancer
-
0:59
dr. karen reckamp evaluates the predictive efficacy of the veristrat in nsclc
-
3:07
targeting angiogenesis in non–small cell lung cancer
-
1:10
dr. drilon on met-amplified lung cancer
-
14:00
unlocking the potential of trop2-targeted therapy: breakthroughs in nsclc therapeutic approaches
-
5:51
karen reckamp, md, ms: results in phase ii advanced lung cancer trial
-
0:37
dr. reckamp on current heat shock protein clinical trials
-
36:39
panel q&a session on acquired resistance with drs. reckamp & owonikoko
-
34:23
management of non-small cell lung cancer (nsclc) with an egfr mutation — karen reckamp, md, ms
-
1:23
targeted therapies for advanced nsclc
-
1:10
dr besse on mechanisms of acquired resistance in egfr advanced nsclc
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
4:28
understanding oncogene-driven lung cancer: targeted therapy advances and challenges
-
1:19
tools available for predicting risk in early stage lung cancer
-
0:49
the importance of metex14 testing in nsclc
-
4:35
managing cns metastases in egfr-positive nsclc
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
4:32
new funding to study how rit1 protein mutation leads to lung cancer